Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05419895 · ClinicalTrials.gov registry record · NA

Early Diagnostic Response Model (EDRM)

A NA study of Autism Spectrum Disorder and Autism, sponsored by Emory University.

Recruiting
Registry status
NA
Development phase
300
Enrollment target
1
Study location

NCT05419895 is a NA study of Autism Spectrum Disorder and Autism that is actively recruiting participants, run by Emory University. The registered enrollment target is 300 participants, above the 134-participant average among 224 other Autism Spectrum Disorder trials with a reported enrollment target (124% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05419895, a NA study of Autism Spectrum Disorder and Autism, is actively recruiting participants, sponsored by Emory University.

RECRUITING
Registry status
NA
Development phase
300 participants
Enrollment target
1
Study location

Study Summary

Babies Can't Wait (BCW) in Georgia will be referring families with children seeking an autism spectrum disorder (autism) diagnosis at the Emory Autism Center's (EAC) Child Screening and Assessment Clinic.The objective of this study is to develop, pilot, and evaluate a diagnostic protocol for children identified at high risk for autism in the BCW early intervention program screening (part of a public health service). This program evaluation will be using pre- and post-data and data collected through the process to evaluate the effectiveness of the EDRM pilot.

Interventions

  • BEHAVIORAL Early Diagnostic Response Model (EDRM)

Study Locations (1)

Georgia

  • Emory Autism Center - Atlanta

Trial Details

FieldValue
Enrollment Target 300 participants
Start Date 2022-06-16
Est. Completion 2026-07
Phase NA

Sponsor

Emory University

1,208 total trials

What the Registry Record Tells You About NCT05419895

The ClinicalTrials.gov registry entry for NCT05419895 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 300 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 134-participant average among 224 other Autism Spectrum Disorder trials with a reported enrollment target (124% higher). The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Autism Spectrum Disorder appearing as the primary indexed condition, and to 1 intervention - of which Early Diagnostic Response Model (EDRM) is the first listed.

NCT05419895 reports 1 study location spanning 1 distinct geographic area - top geographies include Georgia.

Frequently Asked Questions

What is clinical trial NCT05419895 about?

NCT05419895 is a clinical study titled "Early Diagnostic Response Model (EDRM)". Babies Can't Wait (BCW) in Georgia will be referring families with children seeking an autism spectrum disorder (autism) diagnosis at the Emory Autism Center's (EAC) Child Screening and Assessment Clinic.The objective of this study is to develop, pilot, and evaluate a diagnostic protocol for childre...

What is the current status of trial NCT05419895?

This trial is currently recruiting. It is a NA study. The enrollment target is 300 participants. The study started on 2022-06-16. Estimated completion is 2026-07.

What conditions does trial NCT05419895 study?

This clinical trial studies the following conditions: Autism Spectrum Disorder, Autism.

What interventions are being tested in trial NCT05419895?

The interventions under investigation include: Early Diagnostic Response Model (EDRM) (BEHAVIORAL).

Who is sponsoring clinical trial NCT05419895?

This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05419895 being conducted?

This trial has 1 study location across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Autism Spectrum Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.